Elovac-b

ELOVAC-B (Hepatitis-B vaccine B.P. (Recombinant-DNA)) is a sterile suspension containing the purified surface antigen of the virus obtained by culturing genetically engineered Pichia pastoris yeast cells having the surface antigen gene of the Hepatitis B virus.
Elovac-B prevents chronic Hepatitis B virus (HBV) infection and its serious consequences, including liver cirrhosis and hepatocellular cancer (HCC) in Human
beings. The Hepatitis B virus is a double-stranded, enveloped virus of the Hepadnaviridae family.
Indications:

Elovac-B vaccine is indicated for immunization against infection caused by all known subtypes of Hepatitis B virus. Routine Vaccination is recommended for all new born, infants, children and adolescents.
Primary immunization with Elovac-B consists of three intramuscular doses. The second dose given one month after the first and the third dose administered atleast four months after the second dose of Elovac-B.

Immunization Schedule:
1st dose : Given on a fixed date this is the FIRST DOSE
2nd dose : 4 - 10 weeks after the FIRST DOSE
3rd dose : 4 - 20 weeks after the SECOND DOSE
A booster dose is recommended 12 months after the 1st dose.
A second booster dose may be required after 8 years in the high risk population if the antibody titre falls below 10 mIU/ mL

Presentation:
Elovac-B is presented as a sterile ready to use slightly turbid white suspension for intramuscular administration.